285 related articles for article (PubMed ID: 9481403)
1. Pretreatment of donor stimulator cells by 16,16 dimethyl prostaglandin E2 influences the recipient immune response.
Chung SW; Gould B; Zhang R; Hu Y; Levy GA; Gorczynski RM
Surgery; 1998 Feb; 123(2):171-80. PubMed ID: 9481403
[TBL] [Abstract][Full Text] [Related]
2. Tolerance induction to multiple minor histoincompatible cells by activated B cells is associated with preferential activation of Th2 cells.
Gorczynski RM; Kiziroglu F
Transplantation; 1994 Jul; 58(1):51-8. PubMed ID: 8036708
[TBL] [Abstract][Full Text] [Related]
3. Induction of T-cell hyporesponsiveness by intrahepatic modulation of donor antigen-presenting cells.
Chung SW; Gorczynski RM; Dziadkowiec I; Levy GA
Immunology; 1995 Aug; 85(4):582-90. PubMed ID: 7558153
[TBL] [Abstract][Full Text] [Related]
4. The effect of immunomodulation of stimulator antigen presenting cells on subsequent responder T-cell function.
Chung SW; Gould B; Dziadkowiecz I; Gorczynski RM
Immunol Lett; 1997 Mar; 55(3):133-7. PubMed ID: 9161878
[TBL] [Abstract][Full Text] [Related]
5. Induction of transplantation tolerance by allogeneic donor-derived CD4(+)CD25(+)Foxp3(+) regulatory T cells.
Velásquez-Lopera MM; Eaton VL; Lerret NM; Correa LA; Decresce RP; García LF; Jaramillo A
Transpl Immunol; 2008 May; 19(2):127-35. PubMed ID: 18503888
[TBL] [Abstract][Full Text] [Related]
6. Adoptive transfer of unresponsiveness to allogeneic skin grafts with hepatic gamma delta + T cells.
Gorczynski RM
Immunology; 1994 Jan; 81(1):27-35. PubMed ID: 8132216
[TBL] [Abstract][Full Text] [Related]
7. Peptides of a major histocompatibility complex class I (Kb) molecule cause prolongation of skin graft survival and induce specific down-regulatory T cells demonstrable in the mixed lymphocyte reaction.
Brondz BD; Kazansky DB; Chernyshova AD; Ivanov VS
Immunology; 1995 Oct; 86(2):219-23. PubMed ID: 7490121
[TBL] [Abstract][Full Text] [Related]
8. Glutathione depletion of stimulator cells inhibits responder T-cell immunogenicity in vitro and prolongs allograft survival in vivo.
McKenna GJ; Kim PT; Mui AL; Ong CJ; Rotstein OD; Warnock GL; Chung SW
Am J Surg; 2006 May; 191(5):588-92. PubMed ID: 16647342
[TBL] [Abstract][Full Text] [Related]
9. Anergic cells induced by the blockade of CD40-CD154 and CD28-B7 costimulatory pathways act as potent immunoregulatory cells in vitro and vivo.
Cai Y; Zhou PJ; Tang XD
Chin Med J (Engl); 2004 Aug; 117(8):1178-83. PubMed ID: 15361291
[TBL] [Abstract][Full Text] [Related]
10. Investigation of the mechanism of active enhancement of renal allograft survival by blood transfusion.
Quigley RL; Wood KJ; Morris PJ
Immunology; 1988 Mar; 63(3):373-81. PubMed ID: 2965097
[TBL] [Abstract][Full Text] [Related]
11. A role for nonspecific (cyclosporin A) or specific (monoclonal antibodies to ICAM-1, LFA-1, and IL-10) immunomodulation in the prolongation of skin allografts after antigen-specific pretransplant immunization or transfusion.
Gorczynski RM; Wojcik D
J Immunol; 1994 Feb; 152(4):2011-9. PubMed ID: 7907109
[TBL] [Abstract][Full Text] [Related]
12. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
Zhu XH; Chen S; Chen ZK
Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
[TBL] [Abstract][Full Text] [Related]
13. Microheterogeneity in regulatory circuits for T-cell alloresponsiveness.
Gorczynski RM; Macrae S
Immunology; 1981 Dec; 44(4):827-46. PubMed ID: 6172375
[TBL] [Abstract][Full Text] [Related]
14. Donor-specific antigen transfusion-mediated skin-graft tolerance results from the peripheral deletion of donor-reactive CD8+ T cells.
Margenthaler JA; Kataoka M; Flye MW
Transplantation; 2003 Jun; 75(12):2119-27. PubMed ID: 12829922
[TBL] [Abstract][Full Text] [Related]
15. Regional oral tolerance in transgenic 2C mice.
Margenthaler JA; Flye MW
Surgery; 2005 Aug; 138(2):141-9. PubMed ID: 16153420
[TBL] [Abstract][Full Text] [Related]
16. Targeted gene disruption of the heat shock protein 72 gene (hsp70.1) in the donor tissue is associated with a prolonged rejection-free survival in the murine skin allograft model.
Oh KH; Kim JY; Kim D; Lee EM; Oh HY; Seo JS; Han JS; Kim S; Lee JS; Ahn C
Transpl Immunol; 2004 Dec; 13(4):273-81. PubMed ID: 15589740
[TBL] [Abstract][Full Text] [Related]
17. Effect of tumor necrosis factor alpha and intercellular adhesion molecule-1 expression on immunogenicity of murine liver cells in mice.
Bumgardner GL; Li J; Apte S; Heininger M; Frankel WL
Hepatology; 1998 Aug; 28(2):466-74. PubMed ID: 9696013
[TBL] [Abstract][Full Text] [Related]
18. H-2K/H-2D and Mls and I region-associated antigens stimulate helper factor(s) involved in the generation of cytotoxic T lymphocytes.
Scott JW; Ponzio NM; Orosz CG; Finke JH
J Immunol; 1980 May; 124(5):2378-83. PubMed ID: 6444971
[TBL] [Abstract][Full Text] [Related]
19. Regulation of tumor-induced myelopoiesis and the associated immune suppressor cells in mice bearing metastatic Lewis lung carcinoma by prostaglandin E2.
Young MR; Young ME; Kim K
Cancer Res; 1988 Dec; 48(23):6826-31. PubMed ID: 2972359
[TBL] [Abstract][Full Text] [Related]
20. Perturbation of leukocyte function-associated antigen-1/intercellular adhesion molecule-1 results in differential outcomes in cardiac vs islet allograft survival.
Grazia TJ; Gill RG; Gelhaus HC; Doan AN; Sleater ML; Pietra BA
J Heart Lung Transplant; 2005 Sep; 24(9):1410-4. PubMed ID: 16143264
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
